DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Tata Chemicals Limited — Bagging/Receiving of orders/contracts

NSE 2d ago·28 Aug 2026, 7:03 pm

Tata Chemicals

Tata Chemicals has announced that it has received new orders and contracts. This news indicates that the company is actively securing business opportunities, which is a positive signal for its operations.

For investors, this development suggests that Tata Chemicals' order book is growing. An expanding order book generally implies strong demand for the company's products and can lead to improved future revenue and earnings.

Investors should monitor the total value of these new contracts and the sectors they belong to. This information will help in assessing the scale of growth and the company's strategic direction.